Burning Rock Biotech Limited
BNR
$4.60
-$0.10-2.13%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.99M | -16.93M | -22.47M | -22.47M | -24.16M |
| Total Depreciation and Amortization | -- | -- | 18.21M | 18.21M | -- |
| Total Amortization of Deferred Charges | -- | -- | 269.80K | 269.80K | -- |
| Total Other Non-Cash Items | 763.70K | 11.33M | 9.00M | 9.00M | 17.61M |
| Change in Net Operating Assets | -- | -- | -7.22M | -7.22M | -- |
| Cash from Operations | -4.23M | -5.60M | -2.22M | -2.22M | -6.55M |
| Capital Expenditure | -- | -- | -1.12M | -1.12M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 11.60K | 11.60K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.90K | -332.30K | 1.07M | 1.07M | -274.10K |
| Cash from Investing | -137.90K | -332.30K | -45.40K | -45.40K | -274.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -6.98M | -6.98M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.00K | -- | 5.07M | 5.07M | -45.89M |
| Cash from Financing | 300.00 | -- | -264.40K | -264.40K | -6.34M |
| Foreign Exchange rate Adjustments | -494.10K | 7.40K | -453.90K | -453.90K | -171.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.86M | -5.93M | -2.98M | -2.98M | -13.33M |
